American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 281-289 , February 2009

Renal Vascular Endothelial Function in Hypertensive Patients With Type 2 Diabetes Mellitus

Received 1 April 2008 ,Accepted 7 October 2008.

References 

  1. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation. 2007;115:1285–1295
  2. Goligorsky MS, Chen J, Brodsky S. Workshop: Endothelial cell dysfunction leading to diabetic nephropathy: Focus on nitric oxide. Hypertension. 2001;37:744–748
  3. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–1906
  4. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673–2678
  5. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191–196
  6. Schaufele TG, Schlaich MP, Delles C, Klingbeil AU, Fleischmann EH, Schmieder RE. Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress. Kidney Int. 2006;70:1177–1181
  7. Maree A, Peer G, Iaina A, et al. Nitric oxide in streptozotocin-induced diabetes mellitus in rats. Clin Sci (Lond). 1996;90:379–384
  8. Nakagawa T, Sato W, Glushakova O, et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol. 2007;18:539–550
  9. Schmieder RE, Delles C, Mimran A, Fauvel JP, Ruilope LM. Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes. Diabetes Care. 2007;30:1351–1356
  10. Schlaich MP, Jacobi J, John S, Delles C, Fleischmann I, Schmieder RE. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?. Clin Sci (Lond). 2000;99:293–302
  11. Delles C, Klingbeil AU, Schneider MP, Handrock R, Schaufele T, Schmieder RE. The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant. 2004;19:1392–1397
  12. Cupples WA, Braam B. Assessment of renal autoregulation. Am J Physiol Renal Physiol. 2007;292:F1105–F1123
  13. Gomez-Alamillo C, Juncos LA, Cases A, Haas JA, Romero JC. Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds. Hypertension. 2003;42:831–836
  14. Nelson RG, Bennett PH, Beck GJ, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus (Diabetic Renal Disease Study Group). N Engl J Med. 1996;335:1636–1642
  15. Barnett A. Prevention of loss of renal function over time in patients with diabetic nephropathy. Am J Med. 2006;119(suppl 1):S40–S47
  16. Schlaich MP, Schmitt D, Ott C, Schmidt BM, Schmieder RE. Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans. J Hypertens. 2008;26:110–116
  17. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22–27
  18. Calver A, Collier J, Moncada S, Vallance P. Effect of local intra-arterial NG-monomethyl-l-arginine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025–1031
  19. Lyons D, Webster J, Benjamin N. The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-l-arginine in patients with essential hypertension. J Hypertens. 1994;12:1047–1052
  20. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet. 2007;369:1208–1219
  21. Hornig B, Drexler H. Endothelial function and bradykinin in humans. Drugs. 1997;54(suppl 5):S42–S47
  22. Landmesser U, Drexler H. Effect of angiotensin II type 1 receptor antagonism on endothelial function: Role of bradykinin and nitric oxide. J Hypertens Suppl. 2006;24:S39–S43
  23. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–2581
  24. Heine RJ, Dekker JM. Beyond postprandial hyperglycaemia: Metabolic factors associated with cardiovascular disease. Diabetologia. 2002;45:461–475
  25. Kreisberg RA. Diabetic dyslipidemia. Am J Cardiol. 1998;82:67U–73Udiscussion, 85U-86U

 Originally published online as doi:10.1053/j.ajkd.2008.10.041 on December 22, 2008.

PII: S0272-6386(08)01607-7

doi: 10.1053/j.ajkd.2008.10.041

American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 281-289 , February 2009

Article Tools